Page last updated: 2024-08-23

sq-11725 and Hypertrophy, Right Ventricular

sq-11725 has been researched along with Hypertrophy, Right Ventricular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujii, Y; Inagaki, T; Kuwahira, I; Nagai, H; Nara, A; Ogura, S; Pearson, JT; Schwenke, DO; Shimosawa, T; Shirai, M; Tsuchimochi, H; Uemura, K; Umetani, K; Yoshida, K	1

Other Studies

1 other study(ies) available for sq-11725 and Hypertrophy, Right Ventricular

Article	Year
β2-Adrenergic receptor-dependent attenuation of hypoxic pulmonary vasoconstriction prevents progression of pulmonary arterial hypertension in intermittent hypoxic rats. PloS one, 2014, Volume: 9, Issue:10 Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Blood Pressure; Class Ia Phosphatidylinositol 3-Kinase; Disease Models, Animal; Disease Progression; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Nadolol; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Time Factors; Vasoconstriction	2014

Article

Year

β2-Adrenergic receptor-dependent attenuation of hypoxic pulmonary vasoconstriction prevents progression of pulmonary arterial hypertension in intermittent hypoxic rats.

PloS one, 2014, Volume: 9, Issue:10

Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Blood Pressure; Class Ia Phosphatidylinositol 3-Kinase; Disease Models, Animal; Disease Progression; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Nadolol; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Time Factors; Vasoconstriction

2014